Skip to main content
OpenTrials

Clinical trial condition

Mesothelioma, Malignant

Explore clinical trials studying Mesothelioma, Malignant. Study availability and eligibility vary by location and protocol.

225 public trials 44 recruiting studies
Refine in advanced search Browse all conditions

Mesothelioma, Malignant trial results

Recruiting

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

NCT07277413

Conditions
Adenocarcinoma Of Esophagus, Adenocarcinoma of Esophagus, Adenoma, +55 more
Locations
  • Providence Medical Foundation Santa Rosa, California, United States
  • Johns Hopkins Sibley Memorial Hospital Washington D.C., District of Columbia, United States
  • BRCR Global-Coral Springs Coral Springs, Florida, United States
  • Sarah Cannon Research Institute at Florida Cancer Specialists Orlando, Florida, United States
View all 16 locations
View Trial Details
Recruiting

APG-2449 in Patients With Advanced Solid Tumors

NCT03917043

Conditions
Adenoma, Adnexal Diseases, Advanced Solid Cancer, +39 more
Locations
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Fujian Medical University Union Hospital Fuzhou, Fujian, China
  • Fujian Cancer Hospital Fuzhou, Fujian, China
  • Sun-Yat Sen University Cancer Center Guangzhou, Guangdong, China
View Trial Details
Recruiting

A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma

NCT06057935

Conditions
Adenoma, Lung Diseases, Lung Neoplasms, +14 more
Locations
  • University of Chicago (Data Collection Only) Chicago, Illinois, United States
  • University of Michigan (Data Collection Only) Ann Arbor, Michigan, United States
  • Washington University (Data Collection Only) St Louis, Missouri, United States
  • University of Nebraska (Data collection only) Omaha, Nebraska, United States
View all 13 locations
View Trial Details
Recruiting

SW-682 in Advanced Solid Tumors

NCT06251310

Conditions
Adenoma, Advanced Solid Tumor, Lung Diseases, +12 more
Locations
  • HonorHealth Research Institute Scottsdale, Arizona, United States
  • USC Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States
  • UC San Diego Moores Cancer Center Sacramento, California, United States
  • UCLA Hematology-Oncology - Santa Monica Santa Monica, California, United States
View Trial Details
Recruiting

SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma

NCT05568680

Conditions
Adenoma, Adnexal Diseases, Cholangiocarcinoma Recurrent, +26 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • University of Kansas Cancer Center Westwood, Kansas, United States
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Recruiting

A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

NCT06051695

Conditions
Adenoma, Adnexal Diseases, Bronchial Neoplasms, +61 more
Locations
  • Banner Health Gilbert, Arizona, United States
  • UCSD Moores Cancer Center La Jolla, California, United States
  • UCLA Medical Center Los Angeles, California, United States
  • Stanford University Stanford, California, United States
View Trial Details

Related conditions